Clinical Immunoprofiling Reveals that High Numbers of CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors
Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder, Bijaya Sharma, Kristen Felt, Priti Kumari, Tali Mazor, Ethan Cerami, William Lotter, Jennifer Altreuter, Jason Weirather, Ian Dryg, Katharina Hoebel, Michael Manos, Elio Adib, Jennifer D. Curtis, Biagio Ricciuti, Alessandro Di Federico, Fatme Ghandour, Eddy Saad, Xin-an Wang, Federica Pecci, Marta Holovatska, Malini M. Gandhi, Melissa E. Hughes, Tess A. O’Meara, Sabrina J. Chan, Kathleen Pfaff, Panagiotis A. Konstantinopoulos, F. Stephan Hodi, Margaret A. Shipp, Sabina Signoretti, Toni Choueiri, Xiao X. Wei, Sandro Santagata, Glenn J. Hanna, Nancy U. Lin, Sara M. Tolaney, Joyce Liu, Peter K. Sorger, Neal Lindeman, Lynette M. Sholl, Jonathan A. Nowak, David Barbie, Mark M. Awad, Bruce E. Johnson, Scott J. Rodig
doi: https://doi.org/10.1101/2024.12.15.24318012
Joao V Alessi
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.James R Lindsay
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215
Ph.D.Anita Giobbie-Hurder
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215
M.S.Bijaya Sharma
3Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
Ph.D.Kristen Felt
3Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.S.Priti Kumari
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215
M.S.Tali Mazor
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215
Ph.D.Ethan Cerami
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215
Ph.D.William Lotter
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215
Ph.D.Jennifer Altreuter
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215
Ph.D.Jason Weirather
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215
3Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
Ph.D.Ian Dryg
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215
3Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
Ph.D.Katharina Hoebel
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D., Ph.D.Michael Manos
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
3Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
B.S.Elio Adib
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Jennifer D. Curtis
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
B.S.Biagio Ricciuti
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Alessandro Di Federico
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Fatme Ghandour
4Department of Pathology, Brigham & Women’s Hospital, Boston, MA, 02115
M.D.Eddy Saad
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Xin-an Wang
5Department of Biostatistics and Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02215
Ph.D.Federica Pecci
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Marta Holovatska
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.P.H.Malini M. Gandhi
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Melissa E. Hughes
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
B.S.Tess A. O’Meara
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Sabrina J. Chan
6Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, 02115
B.S.Kathleen Pfaff
3Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
Ph.D.Panagiotis A. Konstantinopoulos
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D., Ph.D.F. Stephan Hodi
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
3Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Margaret A. Shipp
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Sabina Signoretti
4Department of Pathology, Brigham & Women’s Hospital, Boston, MA, 02115
M.D.Toni Choueiri
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Xiao X. Wei
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Sandro Santagata
4Department of Pathology, Brigham & Women’s Hospital, Boston, MA, 02115
6Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, 02115
M.D., Ph.D.Glenn J. Hanna
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Nancy U. Lin
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Sara M. Tolaney
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Joyce Liu
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Peter K. Sorger
6Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, 02115
Ph.D.Neal Lindeman
4Department of Pathology, Brigham & Women’s Hospital, Boston, MA, 02115
M.D.Lynette M. Sholl
4Department of Pathology, Brigham & Women’s Hospital, Boston, MA, 02115
M.D.Jonathan A. Nowak
4Department of Pathology, Brigham & Women’s Hospital, Boston, MA, 02115
M.D., Ph.D.David Barbie
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D., Ph.D.Mark M. Awad
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D., Ph.D.Bruce E. Johnson
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
M.D.Scott J. Rodig
3Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215
4Department of Pathology, Brigham & Women’s Hospital, Boston, MA, 02115
M.D., Ph.D.
Article usage
Posted December 20, 2024.
Clinical Immunoprofiling Reveals that High Numbers of CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors
Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder, Bijaya Sharma, Kristen Felt, Priti Kumari, Tali Mazor, Ethan Cerami, William Lotter, Jennifer Altreuter, Jason Weirather, Ian Dryg, Katharina Hoebel, Michael Manos, Elio Adib, Jennifer D. Curtis, Biagio Ricciuti, Alessandro Di Federico, Fatme Ghandour, Eddy Saad, Xin-an Wang, Federica Pecci, Marta Holovatska, Malini M. Gandhi, Melissa E. Hughes, Tess A. O’Meara, Sabrina J. Chan, Kathleen Pfaff, Panagiotis A. Konstantinopoulos, F. Stephan Hodi, Margaret A. Shipp, Sabina Signoretti, Toni Choueiri, Xiao X. Wei, Sandro Santagata, Glenn J. Hanna, Nancy U. Lin, Sara M. Tolaney, Joyce Liu, Peter K. Sorger, Neal Lindeman, Lynette M. Sholl, Jonathan A. Nowak, David Barbie, Mark M. Awad, Bruce E. Johnson, Scott J. Rodig
medRxiv 2024.12.15.24318012; doi: https://doi.org/10.1101/2024.12.15.24318012
Clinical Immunoprofiling Reveals that High Numbers of CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors
Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder, Bijaya Sharma, Kristen Felt, Priti Kumari, Tali Mazor, Ethan Cerami, William Lotter, Jennifer Altreuter, Jason Weirather, Ian Dryg, Katharina Hoebel, Michael Manos, Elio Adib, Jennifer D. Curtis, Biagio Ricciuti, Alessandro Di Federico, Fatme Ghandour, Eddy Saad, Xin-an Wang, Federica Pecci, Marta Holovatska, Malini M. Gandhi, Melissa E. Hughes, Tess A. O’Meara, Sabrina J. Chan, Kathleen Pfaff, Panagiotis A. Konstantinopoulos, F. Stephan Hodi, Margaret A. Shipp, Sabina Signoretti, Toni Choueiri, Xiao X. Wei, Sandro Santagata, Glenn J. Hanna, Nancy U. Lin, Sara M. Tolaney, Joyce Liu, Peter K. Sorger, Neal Lindeman, Lynette M. Sholl, Jonathan A. Nowak, David Barbie, Mark M. Awad, Bruce E. Johnson, Scott J. Rodig
medRxiv 2024.12.15.24318012; doi: https://doi.org/10.1101/2024.12.15.24318012
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2969)
- Dermatology (253)
- Emergency Medicine (445)
- Epidemiology (12807)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4621)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2941)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (932)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4408)
- Nursing (238)
- Nutrition (649)
- Oncology (2295)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (281)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1200)
- Primary Care Research (502)
- Public and Global Health (7004)
- Radiology and Imaging (1544)
- Respiratory Medicine (921)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)